Potential antibacterial activity of berberine against multi drug resistant enterovirulent Escherichia coli isolated from yaks (Poephagus grunniens) with haemorrhagic diarrhoea

Asian Pacific Journal of Tropical Medicine

Volumn 6, Issue 4, 2013, Pages 315-319

  Bandyopadhyay, Samiran ^a,b,c   Patra, Pabitra H ^d   Mahanti, Achintya ^c   Mondal, Dipak K ^a   Dandapat, Premanshu ^a   Bandyopadhyay, Subhasis ^a   Samanta, Indranil ^c   Lodh, Chandan ^c   Bera, Asit K ^b   Bhattacharyya, Debasish ^b   Sarkar, Mihir ^b   Baruah, Kishore K ^b  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b NATIONAL RESEARCH CENTRE ON YAK   (India)

^c WEST BENGAL UNIVERSITY OF ANIMAL AND FISHERY SCIENCES   (India)

^d College of Veterinary Sciences and Animal Husbandry   (India)

Author keywords

Antibacterial activity; Berberine; Escherichia coli; Haemorrhagic diarrhoea; Multi drug resistant enterovirulent; Yak

Indexed keywords

BERBERINE;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BINDING KINETICS; BLOODY DIARRHEA; BROTH DILUTION; CONTROLLED STUDY; DIARRHEAGENIC ESCHERICHIA COLI; DISK DIFFUSION; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANT ENTEROVIRULENT ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; YAK;

ANIMALS; ANTI-BACTERIAL AGENTS; BERBERINE; CATTLE; CATTLE DISEASES; DIARRHEA; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; MICROBIAL SENSITIVITY TESTS; PROTEIN BINDING; SHIGA-TOXIGENIC ESCHERICHIA COLI;

EID: 84876703028     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(13)60063-2     Document Type: Article

References (20)

1. Bandyopadhyay S, Sasmal D, Bora M, Ghosh MK, Sarkar M Antibacterial profile of Rubus idaeus (Raspberry): an in vitro study. Indian J Anim Sci 2008, 78:1247-1249.
2. Bandyopadhyay S, Lodh C, Sarkar M, Ghosh MK, Bera AK, Bhattacharyya D, et al. Prevalence, molecular fingerprinting and drug resistance profile of enterovirulent Escherichia coli isolates from free-ranging yaks of Tawang district, Arunachal Pradesh, India. Trop Anim Health Prod 2012, 1(7). [Epub ahead of print].
3. Bandyopadhyay S, Lodh C, Rahaman H, Bhattacharya D, Bera AK, Ahmed FA, et al. Characterization of shiga toxin producing (STEC) and enteropathogenic Escherichia coli (EPEC) in raw yak (Poephagus grunniens) milk and milk products. Res Vet Sci 2012, 1(5). [Epub ahead of print].
4. Bandyopadhyay S, Mahanti A, Samanta I, Dutta TK, Ghosh MK, Bera AK, et al. Virulence repertoire of Shiga toxin-producing Escherichia coli (STEC) and enterotoxigenic Escherichia coli (ETEC) from diarrhoeic lambs of Arunachal Pradesh, India. Trop Anim Health Prod 2011, 43(3):705-710.
5. Bandyopadhyay S, Sasmal D, Ghosh MK, Bora M, Bhattacharyya M Antibacterial efficacy of neem (Azadirachta indica) against Morexella bovis and Neisseria. Indian J Anim Sci 2008, 78:1105-1107.
6. Bandyopadhyay S, Biswas TK, Sasmal D, Samanta I, Ghosh MK Evaluation of methanolic extract of Allium sativum and Saussurea costus in yaks with infectious keratoconjunctivitis. Indian J Anim Sci 2010, 80:199-202.
7. Birdsall TC, Kelly GS Berberine: therapeutic potential of an alkaloid found in several medicinal plants. Alt Med Rev 1997, 2:94-103.
8. Singh A, Duggal S, Kaur N, Singh J Berberine: Alkaloid with wide spectrum of pharmacological activities. J Nat Products 2010, 3:64-75.
9. Jian-ling J, Guo-qiang H, Zhen M, Pei-ji G Antibacterial mechanisms of berberine and reasons for little resistance of bacteria. Chinese Herb Med 2010, 31:27-35.
10. Freile ML, Giannini F, Pucci G, Sturniolo A, Rodero L, Pucci O, et al. Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis heterophylla. Fitoterapia 2003, 74:702-705.
11. Yu HH, Kim KJ, Cha JD, Kim HK, Lee YE, Choi NY, et al. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. J Med Food 2005, 8:454-461.
12. Imanshahidi M, Hosseinzadeh H Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother Res 2008, 22:999-1012.
13. Han J, Lin H, Huang W Modulating gut microbiota as an anti-diabetic mechanism of berberine. Med Sci Mon 2011, 17:RA164-RA167.
14. Wu M, Wang J, Liu LT Advance of studies on anti-atherosclerosis mechanism of berberine. Chinese J Int Med 2010, 16:188-192.
15. Zeng XH, Zeng XJ, Li YY Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2003, 92:173-176.
16. Lin J, Wang X The synergistic antitumor effects of berberine alpha-hydroxy-beta-decanoylethyl sulfonate with hydroxycamptothecine and its effect on topoisomerase. Yao Xue Xue Bao 2011, 46:390-394.
17. Ji HF, Shen L Berberine: a potential multipotent natural product to combat Alzheimer's disease. Molecules 2011, 16:6732-6740.
18. Islam MM, Chowdhury SR, Kumar GS Spectroscopic and calorimetric studies on the binding of alkaloids berberine, palmatine and coralyne to double stranded RNA polynucleotides. J Phy Chem B 2009, 113:1210-1224.
19. Jeyaseelan EC, Jashothan PTJ In vitro control of Staphylococcus aureus (NCTC 6571) and Escherichia coli (ATCC 25922) by Ricinus communis L. Asian Pac J Trop Biomed 2012, 2(9):717-721.
20. Mohsin M, Haque A, Ali A, Sarwar Y, Bashir S, Tariq A, et al. Effects of ampicillin, gentamicin, and cefotaxime on the release of Shiga toxins from Shiga toxin-producing Escherichia coli isolated during a diarrhoea episode in Faisalabad, Pakistan. Foodborne Path Dis 2010, 7:85-90.